Diimino-piperazine derivatives for use as modulators of cell regulation
AssigneeEmory University
InventorsAlfred H. Merrill JR., Lisa Warden, Dennis C. Liotta
Life of this patent
Estimating the term…
Abstract
Compositions, methods of use, isolation and biosynthesis of diimino-piperazine derivatives useful for the modification of sphingolipid metabolism and other biological functions are described. The preferred derivative is 2,6-bis-(ω-aminobutyl)-3,5-diimino-piperazine. This is a naturally occurring biochemical compound isolated from cells. The diimino-piperazine derivatives are useful as therapeutic agents when administered to patients to treat diseases and disorders involving cell regulation.
Claims20
A diimino-piperazine composition comprising a cationic diimino-piperazine compound that inhibits sphingolipid metabolism, wherein the compound has a molecular weight less than 3000 daltons.
A method for synthesizing a diimino-piperazine compound comprising:
- a. cyclizing bis-nitrile;
- b. replacing amino hydrogens of the cyclized bis-nitrile with a protecting group to produce an intermediate;
- c. alkylating the intermediate;
- and
- d. deprotecting the alkylated intermediate to form the diimino-piperidine compound.
A method for treating a cell signaling pathway disease or disorder comprising administering to a patient having the disease or disorder a diimino-piperazine composition comprising a cationic diimino-piperazine compound that inhibits sphingolipid metabolism, wherein the compound has a molecular weight less than 3000 daltons.
Dependencies are inferred from the claim text.